The molecular features of NAA25-deficient T47D cell lines were analyzed by RNA-seq in this work, and analysis results indicated that many infection and immune associated genes were highly expressed, which suggests that immune therapy may be an effective approach in treating NAA25-overexpressed breast cancer. This evidence concerns the gene NAA25 and breast carcinoma.